Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase

Toxicology

Volumn 229, Issue 1-2, 2007, Pages 42-53

  Suzuki, Hirofumi ^a   Riley, Ronald T ^b   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Fumonisin B1; Hepatotoxicity; Inducible iNOS; Nitric oxide; Sphingosine kinase

Indexed keywords

FUMONISIN B1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; MYCOTOXIN; NITRIC OXIDE; PHOSPHATE; SPHINGOSINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; LIVER REGENERATION; LIVER TOXICITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARCINOGENS, ENVIRONMENTAL; CELL PROLIFERATION; FUMONISINS; HEPATOCYTES; IN SITU NICK-END LABELING; INTERFERON TYPE II; INTERLEUKIN-12; LIVER DISEASES; LIVER REGENERATION; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, MESSENGER; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

SPHINGOIDEA;

EID: 33845291497     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.09.010     Document Type: Article

References (55)

1. Bergmeyer H.U., Horder M., and Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (l-alanine:2-oxoglutarate aminotransferase, EC 2.6.1.2). J. Clin. Chem. Clin. Biochem. 24 (1986) 481-495
2. 1-induced localized activation of cytokine network in mouse liver. Food Chem. Toxicol. 40 (2002) 1483-1491
3. 1. Chem. Biol. Interact. 139 (2002) 317-331
4. Cals-Grierson M.M., and Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 10 (2004) 179-193
5. Chae H.J., Chin H.Y., Lee G.Y., Park H.R., Yang S.K., Chung H.T., Pae H.O., Kim H.M., Chae S.W., and Kim H.R. Carbon monoxide and nitric oxide protect against tumor necrosis factor-α-induced apoptosis in osteoblasts: HO-1 is necessary to mediate the protection. Clin. Chim. Acta 365 (2006) 270-278
6. Chien H.F., Yeh K.Y., Jiang-Shieh Y.F., Wei I.H., Chang C.Y., Chang M.L., and Wu C.H. Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram-positive bacterial constituent, lipoteichoic acid. Neuroscience 133 (2005) 423-436
7. Darnay B.G., and Aggarwal B.B. Early events in TNF signaling: a story of associations and dissociations. J. Leukoc. Biol. 61 (1997) 559-566
8. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann. N.Y. Acad. Sci. 962 (2002) 18-41
9. Dayer J.M. Evidence for the role of biological modulation of IL-1 activity: the role of IL-1Ra. Clin. Exp. Rheumatol. 20 Suppl. 27 (2002) S14-S20
10. 1 affects viability and alters nitric oxide production of a murine macrophage cell line. Int. Immunopharmacol. 2 (2002) 1087-1093
11. 1 toxicity. J. Pharmacol. Exp. Ther. 285 (1998) 317-324
12. Enongene E.N., Sharma R.P., Bhandari N., Miller J.D., Meredith F.I., Voss K.A., and Riley R.T. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol. Sci. 67 (2002) 173-181
13. Gallala H., Macheleidt O., Doering T., Schreiner V., and Sandhoff K. Nitric oxide regulates synthesis of gene products involved in keratinocyte differentiation and ceramide metabolism. Eur. J. Cell Biol. 83 (2004) 667-679
14. Gopee N.V., and Sharma R.P. The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor α and caspase 3 via protein kinase Cα-dependent pathway in porcine renal epithelial cells. Cell Biol. Toxicol. 20 (2004) 197-212
15. He Q., Riley R.T., and Sharma R.P. Fumonisin-induced tumor necrosis factor-α expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. Toxicol. Appl. Pharmacol. 174 (2001) 69-77
16. 1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. Toxicology 207 (2005) 137-147
17. He Q., Suzuki H., Sharma N., and Sharma R.P. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid metabolizing systems in mouse liver. Toxicol. Sci. 94 (2006) 388-397
18. Horton J.W. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 189 (2003) 75-88
19. 1 carcinogenicity in a 2-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109 Suppl. 2 (2001) 277-282
20. 1. IARC monograph on the evaluation of carcinogenic risks to humans. IARC 822 (1992) 301-366
21. James L.P., Mayeux P.R., and Hinson J.A. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31 (2003) 1499-1506
22. Janssen-Heininger Y.M., Poynter M.E., and Baeuerle P.A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic. Biol. Med. 28 (2000) 1317-1327
23. 1 renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. Toxicol. Appl. Pharmacol. 176 (2001) 118-126
24. Kim S.-H., Johnson V.J., and Sharma R.P. Mercury inhibits nitric oxide production but activates pro-inflammatory cytokine expression in murine macrophage: differential modulation of NFκB and p38 MAPK signaling pathways. Nitric Oxide 7 (2002) 67-74
25. Kleinert H., Schwarz P.M., and Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384 (2003) 1343-1364
26. Kroncke K.D. Nitrosative stress and transcription. Biol. Chem. 384 (2003) 1365-1377
27. Laubach V.E., Foley P.L., Shockey K.S., Tribble C.G., and Kron I.L. Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice. Am. J. Physiol. 275 (1998) H2211-H2218
28. Le Stunff H., Galve-Roperh I., Peterson C., Milstien S., and Spiegel S. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell Biol. 158 (2002) 1039-1049
29. Maceyka M., Payne S.G., Milstien S., and Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 1585 (2002) 193-201
30. Marasas W.F. Discovery and occurrence of the fumonisins: a historical perspective. Environ. Health Perspect. 109 Suppl. 2 (2001) 239-243
31. 1 on inducible nitric oxide synthase and cyclooxygenase-2 in LPS-stimulated J774A.1 cells. Life Sci. 67 (2000) 2845-2853
32. Merrill Jr. A.H., Sullards M.C., Wang E., Voss K.A., and Riley R.T. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109 Suppl. 2 (2001) 283-289
33. Min J.K., Yoo H.S., Lee E.Y., Lee W.J., and Lee Y.M. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal. Biochem. 303 (2002) 167-175
34. Morio L.A., Chiu H., Sprowles K.A., Zhou P., Heck D.E., Gordon M.K., and Laskin D.L. Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol. Appl. Pharmacol. 172 (2001) 44-51
35. 1 protection against acute liver injury. Gut 47 (2000) 553-562
36. Pettus B.J., Chalfant C.E., and Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585 (2002) 114-125
37. Pyne S., and Pyne N.J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349 (2000) 385-402
38. Riebeling C., Allegood J.C., Wang E., Merrill Jr. A.H., and Futerman A.H. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J. Biol. Chem. 278 (2003) 43452-43459
39. Riley R.T., Wang E., Schroeder J.J., Smith E.R., Plattner R.D., Abbas H., Yoo H.S., and Merrill Jr. A.H. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins 4 (1996) 3-15
40. Riley R.T., Enongene E., Voss K.A., Norred W.P., Meredith F.I., Sharma R.P., Spitsbergen J., Williams D.E., Carlson D.B., and Merrill Jr. A.H. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109 Suppl. 2 (2001) 301-308
41. Schwentker A., Vodovotz Y., Weller R., and Billiar T.R. Nitric oxide and wound repair: role of cytokines?. Nitric Oxide 7 (2002) 1-10
42. 1 hepatotoxicity in mice by depletion of T cells with anti-Thy1.2. Toxicology 223 (2006) 191-201
43. 1 in human embryonic kidney (HEK-293) cells. Chem. Biol. Interact. 151 (2004) 33-42
44. 1. J. Comp. Pathol. 117 (1997) 371-381
45. Sharma R.P., Bhandari N., He Q., Riley R.T., and Voss K.A. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. Toxicology 159 (2001) 69-79
46. Sharma R.P., He Q., and Johnson V.J. Deletion of IFN-γ reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors. J. Interferon Cytokine Res. 23 (2003) 13-23
47. 1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor α. Cytokine 24 (2003) 226-236
48. Spiegel S., and Milstien S. Functions of a new family of sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 1484 (2000) 107-116
49. 1 activates serine palmitoyltransferase and sphingosine kinase, enzymes important in sphingolipid metabolism, in mouse liver. Toxicol. Sci. 84 (2005) 16 abstract
50. Sydenham E.W., Thiel P.G., Marasas W.F.O., Shephard G.S., Vanschalkwyk D.J., and Koch K.R. Natural occurrence of some fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, Southern Africa. J. Agric. Food Chem. 38 (1990) 1900-1903
51. Tolleson W.H., Dooley K.L., Sheldon W.G., Thurman J.D., Bucci T.J., and Howard P.C. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. Adv. Exp. Med. Biol. 392 (1996) 237-250
52. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J. Biochem. Mol. Toxicol. 12 (1998) 281-289
53. 1 in B6CF1 mice and Fischer 344 rats. Fundam. Appl. Toxicol. 24 (1995) 102-110
54. Wang E., Norred W.P., Bacon C.W., Riley R.T., and Merrill Jr. A.H. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266 (1991) 14486-14490
55. Xia P., Wang L., Gamble J.R., and Vadas M.A. Activation of sphingosine kinase by tumor necrosis factor-α inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274 (1999) 34499-34505